Latest / The Well-Built Life / Understanding Hashimoto Thyroiditis: A Comprehensive Guide
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:02Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:06Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple, practical habits that help you feel stronger, healthier,
- 0:17Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:22Speaker 1: and let's dive in. So let's dive into the nitty
- 0:25Speaker 1: gritty here. At the heart of hypothyroidism, Hashimoto's thyroiditis stands
- 0:31Speaker 1: as the primary cause, especially in iodine-fortified countries. It's a
- 0:36Speaker 1: silent assault on the thyroid gland driven by a self-destructive
- 0:41Speaker 1: immune response.
- 0:42Speaker 2: Absolutely. The immune system turns on the thyroid, producing antibodies
- 0:47Speaker 2: that target and destroy thyroid cells. This makes the thyroid
- 0:51Speaker 2: less effective, leading to a drop in the production of
- 0:54Speaker 2: thyroid hormones, which are essential for metabolic balance.
- 0:57Speaker 1: That's right. Key symptoms start to emerge when thyroid hormones
- 1:01Speaker 1: fall too low, fatigue, weight gain, and feeling cold are common.
- 1:07Speaker 1: But let's unpack the more serious end of the spectrum.
- 1:10Speaker 1: Myxedema coma, for instance, is a life-threatening emergency.
- 1:14Speaker 2: Precisely. It's a severe manifestation of hypothyroidism where patients may
- 1:19Speaker 2: experience hypothermia, bradycardia, and lethargy. It's a critical alert that
- 1:25Speaker 2: something's really wrong.
- 1:27Speaker 1: Yes. And the treatment is multifaceted, supportive care, corticosteroids, replacement therapy,
- 1:33Speaker 1: and addressing any underlying factors. But as we dig deeper,
- 1:38Speaker 1: hashy toxicosis is another fascinating phenomenon.
- 1:41Speaker 2: Exactly. It's like the thyroid storm in reverse. In this phase,
- 1:46Speaker 2: Teresa burst of autoantibody production leading to hyperthyroid symptoms, tachycardia,
- 1:51Speaker 2: heat intolerance, and weight loss. We need to catch it
- 1:54Speaker 2: early to prevent serious complications. Right.
- 1:57Speaker 1: And the diagnostic journey is crucial. A simple TSH and
- 2:01Speaker 1: free T4 test can show us whether we are dealing
- 2:04Speaker 1: with hypothyroidism or subclinical issues. High TSH and low free
- 2:09Speaker 1: T4 are classic signs, but it's the presence of those
- 2:13Speaker 1: specific antithyroid antibodies, TP-AB and TG-AB, that really pin the
- 2:18Speaker 1: diagnosis on Hashimoto's.
- 2:20Speaker 2: Not to mention the physical signs can be quite telling.
- 2:24Speaker 2: A smooth, diffusely enlarged thyroid gland, delayed tendon reflexes, dry skin,
- 2:29Speaker 2: and fragile hair. It's like the gland is taking its
- 2:32Speaker 2: time to announce it's having a bad day.
- 2:34Speaker 1: Yes, and the management strategy is tailored. For those with
- 2:39Speaker 1: high TSH, we start with levothyroxine. It's a stepwise approach,
- 2:44Speaker 1: adjusting doses based on TSH responses to keep the thyroid
- 2:49Speaker 1: functioning at an optimal level.
- 2:51Speaker 2: But we can't forget the context. Patients with Hashimoto's are
- 2:55Speaker 2: at a slightly higher risk of adrenal insufficiency, so we'd
- 2:59Speaker 2: want to check those basal cortisol levels before jumping into levothyroxine.
- 3:04Speaker 1: Agreed, and then to raise the papillary thyroid carcinoma risk,
- 3:09Speaker 1: which we need to monitor closely with any palpable nodules.
- 3:13Speaker 2: It's a comprehensive conversation, but essential for our listeners to understand.
- 3:19Speaker 2: Hashimoto's thyroiditis isn't just about the hormones. It's a system-wide
- 3:25Speaker 2: interplay of immune, metabolic, and even psychological factors.
- 3:29Speaker 1: So, let's dive into the mechanisms and diagnosis of Hashimoto's thyroiditis. First,
- 3:36Speaker 1: let's talk about the role of autoantibodies in destroying thyroid cells.
- 3:41Speaker 1: Can you break down how this actually works, Thomas?
- 3:44Speaker 2: Absolutely, Rachel. In Hashimoto's, the immune system mistakenly attacks the
- 3:49Speaker 2: thyroid gland. producing autoantibodies like antithyroid peroxidase, Apoend, antithyroglobulin, Taichi antibodies.
- 3:58Speaker 2: These autoantibodies target crucial thyroid enzymes and proteins, disrupting the
- 4:03Speaker 2: synthesis of thyroid hormones.
- 4:06Speaker 1: Right, and that's the crucial nuance here. How exactly do
- 4:10Speaker 1: these antibodies target specific enzymes and proteins in the thyroid cells?
- 4:15Speaker 2: Essentially, the immune system recognizes thyroid, specific antigens as foreign,
- 4:21Speaker 2: leading to an inflammatory response that damages the thyroid follicular cells.
- 4:26Speaker 2: TPO antibodies bind to the thyroid peroxidase enzyme, interfering with
- 4:31Speaker 2: the iodination of tyrosine residues, which is a key step
- 4:35Speaker 2: in producing thyroid hormones like T3 and T4. Similarly, TG
- 4:41Speaker 2: antibodies attack thyroglobulin, a protein that stores thyroid hormones, This
- 4:46Speaker 2: destruction leads to a gradual decrease in thyroid hormone production.
- 4:50Speaker 1: That's a vivid way to put it. So, how does
- 4:54Speaker 1: the diagnosis of Hashimoto's thyroiditis typically play out in clinical practice?
- 4:59Speaker 2: The diagnostic journey starts with blood tests. We look for
- 5:03Speaker 2: the presence of TPO and TG antibodies, which are present
- 5:06Speaker 2: in 95% and 60-80% of Hashimoto's patients, respectively. If these
- 5:12Speaker 2: autoantibodies are found, The next step is to assess TSH
- 5:16Speaker 2: and free T4 levels. A high TSH and low free
- 5:19Speaker 2: T4 usually confirms primary hypothyroidism.
- 5:23Speaker 1: And what about the initial clinical assessments? Once you suspect Hashimoto's,
- 5:29Speaker 1: what immediate steps do you take?
- 5:31Speaker 2: Right. It's a multi-step process. First, perform an ABDE assessment
- 5:36Speaker 2: to check for any instability signs. If a patient presents
- 5:39Speaker 2: with hypothermia, bradycardia, and lethargy, We suspect Myxedema Coma, a
- 5:45Speaker 2: severe form of hypothyroidism. Treatment involves immediate intubation and mechanical
- 5:50Speaker 2: ventilation if necessary, IV access, and continuous monitoring of vital signs.
- 5:56Speaker 1: Interesting. And what about patients who seem to be in
- 5:59Speaker 1: a hyperthyroid phase, experiencing symptoms like tachycardia and heat intolerance?
- 6:07Speaker 1: How do we handle those cases differently?
- 6:09Speaker 2: Ah, Hashitoxicosis. This is a transient phase in Hashimoto's where
- 6:14Speaker 2: teres a burst of autoantibody activity, leading to a temporary
- 6:18Speaker 2: hyperthyroid state. We manage these patients with antithyroid drugs to
- 6:23Speaker 2: lower thyroid hormone levels and beta blockers to control heart rate.
- 6:28Speaker 2: It's a delicate balance, but crucial to prevent potential cardiac complications.
- 6:33Speaker 1: That's a comprehensive approach. So, as we wrap up this section...
- 6:38Speaker 1: What are the key takeaways for our listeners?
- 6:41Speaker 2: The main points are understand the role of autoantibodies in
- 6:44Speaker 2: destroying thyroid cells, recognize the diagnostic criteria involving TPOAB and TJAB,
- 6:51Speaker 2: and perform initial clinical assessments to determine severity. Monitoring and
- 6:56Speaker 2: adjusting treatment based on TSH and free T4 levels are essential.
- 7:01Speaker 2: And always, always check for any signs of adrenal insufficiency
- 7:05Speaker 2: or risk of papillary thyroid carcinoma.
- 7:07Speaker 1: Great, Thomas. That covers everything we need to know about
- 7:11Speaker 1: the mechanisms and diagnosis of Hashimoto's. Next time, we will
- 7:16Speaker 1: get into the treatment and management aspects. Stay tuned. So, Thomas,
- 7:22Speaker 1: when we move into treatment, it's all about managing those
- 7:25Speaker 1: TSH and free T4 levels effectively. Let's start with the basics.
- 7:30Speaker 1: What's the deal with TSH and free T4?
- 7:32Speaker 2: Great, Rachel. It's crucial to understand that these levels are
- 7:36Speaker 2: like the master key and the front door to your thyroid.
- 7:40Speaker 2: 2SH is basically the brain signal to the thyroid to
- 7:43Speaker 2: produce hormones. When 2SH levels are high, it means the
- 7:47Speaker 2: brain is shouting, make more hormones because the thyroid can't
- 7:51Speaker 2: keep up. Free T4, on the other hand, is the
- 7:54Speaker 2: actual hormone that does all the work once it gets
- 7:57Speaker 2: to your cells. Right.
- 7:59Speaker 1: And that's why it's important to align both of these
- 8:01Speaker 1: levels to ensure the thyroid's output is just right. Now,
- 8:06Speaker 1: let's walk through the step-by-step process of how we get there.
- 8:10Speaker 1: Starting with TSH. What's the first thing clinicians should look for?
- 8:14Speaker 2: The first step is to check if TSH is above
- 8:17Speaker 2: 10 mL. If it's high, it's a pretty strong sign
- 8:20Speaker 2: that levothyroxine is needed. We have got to start the
- 8:24Speaker 2: treatment here because the high TSH is indicating that the
- 8:27Speaker 2: thyroid isn't keeping up with the body's needs.
- 8:29Speaker 1: Exactly. And once we start the treatment with levothyroxine, the
- 8:33Speaker 1: next step is to monitor TSH levels within three to
- 8:37Speaker 1: six weeks. This is like a tuning check. Up after
- 8:40Speaker 1: adjusting the engine, how do we know if we need
- 8:43Speaker 1: to boost the dose or if it's too much?
- 8:45Speaker 2: Right. You will want to titrate based on the TSH response.
- 8:49Speaker 2: If the TSH is still high, you may need to
- 8:52Speaker 2: increase the dose. Conversely, if it drops too low, you
- 8:56Speaker 2: might need to reduce the dose. The goal is to
- 8:58Speaker 2: get that TSH to around the normal range, which is
- 9:01Speaker 2: usually between 0.4 and 4.0 muon. But remember, we are
- 9:06Speaker 2: not just looking at numbers, we are looking at outcomes.
- 9:09Speaker 1: True, and here is where it gets interesting. Certain patient
- 9:13Speaker 1: factors come into play. For instance, age plays a big
- 9:17Speaker 1: role in patients under 65 to 70 we are more
- 9:20Speaker 1: likely to initiate treatment sooner to hit that target TSH.
- 9:25Speaker 1: Why is that?
- 9:26Speaker 2: Well, Rachel, in younger patients, the thyroid's effects are more pronounced,
- 9:30Speaker 2: and they may benefit more from hormone replacement to avoid
- 9:33Speaker 2: long-term complications. That's key in terms of managing hypothyroidism effectively. Also,
- 9:40Speaker 2: fertility is a big concern here. If we are dealing
- 9:43Speaker 2: with a patient who wants to conceive... We know that
- 9:45Speaker 2: treating hypothyroidism optimally can significantly impact pregnancy outcomes.
- 9:51Speaker 1: Exactly. Not only do we need to focus on the
- 9:53Speaker 1: TSH and free T4, but also on individual needs. For example,
- 9:58Speaker 1: a 30-year woman hoping to get pregnant might benefit more
- 10:04Speaker 1: from active treatment than someone in their 60s. This is
- 10:07Speaker 1: because the effects of hypothyroidism on fertility are more immediate
- 10:12Speaker 1: and severe in the younger group.
- 10:14Speaker 2: Absolutely. It's like looking at a racehorse versus a mule.
- 10:18Speaker 2: You are looking at the performance curve. The younger you are,
- 10:21Speaker 2: the more responsive your body is to treatment. And it's
- 10:24Speaker 2: not just about numbers. It's about the holistic impact on
- 10:28Speaker 2: daily function and quality of life, especially when it comes
- 10:31Speaker 2: to pregnancy planning.
- 10:33Speaker 1: So, to wrap up this segment, the takeaway is that
- 10:36Speaker 1: TSH and free T4 levels are intertwined, and the treatment
- 10:40Speaker 1: process is a dynamic, personalized journey. Age and fertility are
- 10:45Speaker 1: just two of the many factors that we need to consider.
- 10:48Speaker 1: when managing hypothyroidism effectively. So how does the quality of
- 10:52Speaker 1: life for someone with Hashimoto's thyroiditis actually play out day
- 10:56Speaker 1: to day? I mean, we know there are physical symptoms
- 11:01Speaker 1: like fatigue, weight gain, and hair loss. But is there
- 11:05Speaker 1: more to it?
- 11:05Speaker 2: Absolutely, Rachel. Beyond the obvious physical symptoms, Hashimoto's can have
- 11:10Speaker 2: a profound impact on neurological and cognitive functions. Patients often
- 11:15Speaker 2: report feeling foggy or having trouble focusing. memory problems are common,
- 11:20Speaker 2: and anxiety and depression can become significant issues as well.
- 11:23Speaker 1: Right, and that's the crucial nuance here. It's not just
- 11:26Speaker 1: about the physical ailments, but how these conditions can really
- 11:29Speaker 1: impact a person's daily functioning and mental state. Has there
- 11:33Speaker 1: been any research on how these neurological symptoms play out
- 11:37Speaker 1: over time?
- 11:38Speaker 2: There have been several studies that show a direct link
- 11:41Speaker 2: between hypothyroidism and neuropsychiatric symptoms. For instance, A study found
- 11:47Speaker 2: that even mild thyroid dysfunction can lead to cognitive decline,
- 11:51Speaker 2: especially affecting executive function and attention. It's like the thyroid
- 11:56Speaker 2: is the conductor, and when it's not working well, the
- 11:59Speaker 2: entire orchestra is off-tune.
- 12:01Speaker 1: That's wild when you look at the raw numbers. But
- 12:04Speaker 1: moving on, what about the increased risk of papillary thyroid
- 12:08Speaker 1: carcinoma in patients with Hashimoto's? How does that factor into
- 12:12Speaker 1: all of this?
- 12:12Speaker 2: That's a good point, Rachel. The link between Hashimoto's and
- 12:16Speaker 2: papillary thyroid carcinoma is well documented. Studies suggest that individuals
- 12:22Speaker 2: with Hashimoto's have a 2 to 7 times higher risk
- 12:25Speaker 2: of developing papillary thyroid carcinoma compared to the general population.
- 12:30Speaker 2: It's not clear exactly why, but one theory is that
- 12:34Speaker 2: the chronic inflammation and autoimmune process might be contributing to
- 12:38Speaker 2: cellular changes that lead to cancer.
- 12:40Speaker 1: Interesting. So, when a patient with Hashimoto's presents with a
- 12:44Speaker 1: thyroid nodule, what's the first step? What should be done
- 12:49Speaker 1: to investigate further?
- 12:50Speaker 2: You'd take a methodical approach. First, you'd order an ultrasound
- 12:54Speaker 2: to visualize the nodule and check for any suspicious features
- 12:57Speaker 2: like irregular borders or calcifications. Then, you might consider doing
- 13:02Speaker 2: a fine needle aspiration biopsy if the ultrasound findings are concerning.
- 13:06Speaker 2: This helps rule out malignancy and guides treatment decisions.
- 13:10Speaker 1: That makes sense. It's a balance between being proactive and
- 13:14Speaker 1: avoiding unnecessary intervention. I guess this just underscores the importance
- 13:19Speaker 1: of regular checkups and thyroid function monitoring, especially for those
- 13:23Speaker 1: with a history of autoimmune disorders.
- 13:26Speaker 2: Exactly. Regular monitoring is crucial because, as I mentioned, papillary
- 13:31Speaker 2: thyroid carcinoma is more common in Hashimoto's patients. But it's
- 13:36Speaker 2: not a death sentence. With early detection, the prognosis can
- 13:40Speaker 2: be very good. The key is catching any changes early.
- 13:44Speaker 1: Absolutely. It's all about the holistic approach to managing this condition. Thanks, Thomas,
- 13:51Speaker 1: for breaking it down. I think our listeners now have
- 13:54Speaker 1: a much better understanding of the broader impacts of Hashimoto's.
- 13:59Speaker 2: My pleasure, Rachel. And remember, it's not just about the thyroid,
- 14:03Speaker 2: it's about the whole person. That's why a multidisciplinary approach
- 14:07Speaker 2: is so important in treating Hashimoto's thyroiditis. So?
- 14:11Speaker 1: As we wrap up our discussion on Hashimoto's thyroiditis, let's
- 14:15Speaker 1: talk about the future outlook and key takeaways. The landscape
- 14:20Speaker 1: of research is ever-evolving, and staying ahead means staying informed. Thomas,
- 14:26Speaker 1: what are some of the latest research trends we should
- 14:28Speaker 1: pay attention to?
- 14:29Speaker 2: Right, and that's the crucial nuance here, Rachel. One of
- 14:33Speaker 2: the key areas is understanding genetic and environmental factors that
- 14:37Speaker 2: could predispose someone to Hashimoto's, Recent studies are exploring the
- 14:41Speaker 2: interplay between genetics and stress, which can trigger the autoimmune response. Also,
- 14:47Speaker 2: Therese knew research indicating that gut health might play a
- 14:50Speaker 2: significant role, with certain bacteria influencing the immune system.
- 14:55Speaker 1: That's wild when you look at the raw numbers. And
- 14:58Speaker 1: it makes sense, too. The gut plays a vital role
- 15:01Speaker 1: in overall health, so it's not surprising to see it
- 15:04Speaker 1: linked to autoimmune conditions. On the treatment front? What do
- 15:08Speaker 1: you see as the next big advancement?
- 15:10Speaker 2: Exactly another interesting direction. Current drug treatments are effective but
- 15:15Speaker 2: not without side effects. Research is now focusing on using
- 15:19Speaker 2: immunomodulatory therapies to dampen the immune response specifically against the thyroid.
- 15:24Speaker 2: Some trials have shown promising results with agents like prednisone
- 15:28Speaker 2: and leflinomide, which can potentially modulate the immune system to
- 15:32Speaker 2: reduce inflammation and damage.
- 15:34Speaker 1: That's exciting. And it's not just about treatments. Ongoing monitoring
- 15:40Speaker 1: is crucial, isn't it? How should patients be approaching this?
- 15:44Speaker 2: Absolutely. The idea is to be proactive rather than reactive.
- 15:49Speaker 2: Patients should have regular checkups to monitor TSH levels and
- 15:53Speaker 2: thyroid hormone levels. This helps in catching any subtle changes early.
- 15:57Speaker 2: The risk for complications like myxedema coma is real, so
- 16:01Speaker 2: prompt attention to symptoms is key. Agreed.
- 16:05Speaker 1: And let's not forget that managing Hashimoto's is a multifaceted approach.
- 16:10Speaker 1: It's not just about the medication, but also lifestyle changes.
- 16:14Speaker 1: Do you have any strategies for long-term management that you recommend?
- 16:18Speaker 2: Great question. For those dealing with Hashimoto's, a few actionable
- 16:22Speaker 2: steps include maintaining a balanced diet, managing stress through mindfulness
- 16:26Speaker 2: or other techniques, and getting regular exercise. These lifestyle factors
- 16:31Speaker 2: can help stabilize hormone levels. and improve overall well-being.
- 16:35Speaker 1: Exactly. It's all about that holistic approach, making sure that
- 16:39Speaker 1: every aspect of health is taken care of. It's really
- 16:42Speaker 1: about empowering the patient to take control of their health
- 16:45Speaker 1: and prevent complications. What would you say to someone who's
- 16:48Speaker 1: newly diagnosed and feeling overwhelmed?
- 16:51Speaker 2: For them, I'd say focus on small, consistent changes. It's
- 16:55Speaker 2: not about achieving perfection overnight, but making a plan and
- 16:59Speaker 2: sticking to it. Educate yourself about the condition, work closely
- 17:03Speaker 2: with your healthcare provider, and remember that you are not alone.
- 17:07Speaker 2: Support groups and online communities can provide a wealth of
- 17:10Speaker 2: information and emotional support.
- 17:12Speaker 1: Absolutely. It's all about that journey and taking it one
- 17:16Speaker 1: step at a time. Thanks, Thomas, for your insights. This
- 17:21Speaker 1: has really given us a well-rounded view of the future
- 17:24Speaker 1: outlook for Hashimoto's.
- 17:26Speaker 2: My pleasure, Rachel. And remember... The journey towards managing Hashimoto's
- 17:31Speaker 2: is a marathon, not a sprint. With the right tools
- 17:34Speaker 2: and support, patients can lead healthy, fulfilling lives.
- 17:38Speaker 1: That brings us to the end of today's episode. Thank
- 17:40Speaker 1: you so much for spending part of your day with me.
- 17:43Speaker 1: If you found this episode's tips helpful and want to
- 17:46Speaker 1: make sure you don't miss the next conversation, please take
- 17:49Speaker 1: a quick second to hit that subscribe or follow button
- 17:52Speaker 1: on whatever platform you are listening on. It's a completely
- 17:55Speaker 1: free way to support the show and helps more people
- 17:58Speaker 1: find us. This podcast is independently produced, so if you
- 18:02Speaker 1: are ever in a position where you would like to
- 18:04Speaker 1: help keep it running, we do accept small donations. You
- 18:08Speaker 1: can find a link right in the episode description below
- 18:11Speaker 1: to buy us a coffee or contribute what you can.
- 18:14Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 18:19Speaker 1: and we will talk again soon.